Hangzhou Minsheng Healthcare Co., Ltd.

301507

CNE1000068Q3

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 18:00:00 2024-07-04 EDT			5-day change	1st Jan Change
12.94 ^CNY	+1.81%		+1.97%	-21.58%

06-07	Hangzhou Minsheng Healthcare Co., Ltd. Announces Final Dividend on A Shares for the Year 2023, Payable on 14 June 2024	CI
05-20	Hangzhou Minsheng Healthcare Co., Ltd. Approves Cash Dividend for the Year 2023	CI

Hangzhou Minsheng Healthcare Co., Ltd. Announces Final Dividend on A Shares for the Year 2023, Payable on 14 June 2024

June 07, 2024 at 03:34 pm

Hangzhou Minsheng Healthcare Co., Ltd. announced 2023 final profit distribution plan to be implemented (A shares): Cash dividend/10 shares (tax included): CNY1.00000000. Record date: 13 June 2024, Ex-date: 14 June 2024 and Payment date: 14 June 2024.

Latest news about Hangzhou Minsheng Healthcare Co., Ltd.

Hangzhou Minsheng Healthcare Co., Ltd. Announces Final Dividend on A Shares for the Year 2023, Payable on 14 June 2024	06-07	CI
Hangzhou Minsheng Healthcare Co., Ltd. Approves Cash Dividend for the Year 2023	05-20	CI
Hangzhou Minsheng Healthcare Co., Ltd. Approves Board Appointments	05-20	CI
Hangzhou Minsheng Healthcare Co., Ltd. Proposes Final Dividend for the Year 2023	04-23	CI
Hangzhou Minsheng Healthcare Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-23	CI
Hangzhou Minsheng Healthcare Co., Ltd.(XSEC:301507) added to S&P Global BMI Index	03-17	CI

Chart Hangzhou Minsheng Healthcare Co., Ltd.

Duration

Period

Chart Hangzhou Minsheng Healthcare Co., Ltd.

More charts

Company Profile

Hangzhou Minsheng Healthcare Co Ltd is a China-based company principally engaged in the research, development, production and sales of vitamin and mineral over-the-counter (OTC) medicines and health food. The Company's main products include multidimensional element pieces (21), multivitamin mineral tablets, other mineral OTC products, other vitamin mineral health food, vitamin mineral food, probiotic series health food, probiotics series food, probiotics series daily chemicals and others. The Company mainly operates its businesses in the domestic market.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
HANGZHOU MINSHENG HEALTHCARE CO., LTD.	-21.58%	623M
ELI LILLY AND COMPANY	+56.86%	809B
NOVO NORDISK A/S	+39.52%	624B
JOHNSON & JOHNSON	-7.15%	351B
ABBVIE INC.	+7.35%	289B
ASTRAZENECA PLC	+13.74%	240B
NOVARTIS AG	+13.83%	220B
ROCHE HOLDING AG	-0.49%	219B
AMGEN INC.	+7.93%	166B
PFIZER, INC.	-2.52%	157B